FR2034951A1 - - Google Patents

Info

Publication number
FR2034951A1
FR2034951A1 FR7009184A FR7009184A FR2034951A1 FR 2034951 A1 FR2034951 A1 FR 2034951A1 FR 7009184 A FR7009184 A FR 7009184A FR 7009184 A FR7009184 A FR 7009184A FR 2034951 A1 FR2034951 A1 FR 2034951A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7009184A
Other languages
French (fr)
Other versions
FR2034951B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2034951A1 publication Critical patent/FR2034951A1/fr
Application granted granted Critical
Publication of FR2034951B1 publication Critical patent/FR2034951B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/27—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P31/00—Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7009184A 1969-03-14 1970-03-13 Expired FR2034951B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80740569A 1969-03-14 1969-03-14

Publications (2)

Publication Number Publication Date
FR2034951A1 true FR2034951A1 (en) 1970-12-18
FR2034951B1 FR2034951B1 (en) 1974-02-01

Family

ID=25196294

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7009184A Expired FR2034951B1 (en) 1969-03-14 1970-03-13

Country Status (10)

Country Link
BE (1) BE747348A (en)
BR (1) BR6915068D0 (en)
CA (1) CA968348A (en)
CH (3) CH553740A (en)
DE (1) DE2011969A1 (en)
ES (1) ES377342A1 (en)
FR (1) FR2034951B1 (en)
GB (2) GB1282661A (en)
IL (1) IL33949A (en)
NL (1) NL7003298A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2183041A1 (en) * 1972-04-27 1973-12-14 Upjohn Co

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4008263A (en) * 1969-03-14 1977-02-15 The Upjohn Company Racemic fluoro-substituted PGF2 .sub.α analogs
US3983153A (en) * 1969-03-14 1976-09-28 The Upjohn Company Racemic fluoro-substituted PGE2 analogs
US3993687A (en) * 1969-03-14 1976-11-23 The Upjohn Company Racemic fluoro-substituted PGB2 analogs
US3940438A (en) * 1971-05-24 1976-02-24 Alza Corporation Crystalline racemic 9α,11α,15(S)-trihydroxy-5-cis,13-trans-prostadienoic acid
US3988361A (en) * 1971-11-16 1976-10-26 The Upjohn Company 8β-PGE2 and related compounds
US4056555A (en) * 1975-02-24 1977-11-01 The Upjohn Company 2,2-Difluoro-16-phenoxy-PGA2 analogs
US4059614A (en) * 1975-02-24 1977-11-22 The Upjohn Company 2,2-Difluoro-16-phenoxy-PGE1 analogs
US4001300A (en) * 1975-02-24 1977-01-04 The Upjohn Company 2,2-Difluoro-16-phenoxy-PGF2 analogs
US4056557A (en) * 1975-02-24 1977-11-01 The Upjohn Company 2,2-Difluoro-16-phenoxy-PGF1 analogs
US4056554A (en) * 1975-02-24 1977-11-01 The Upjohn Company 2,2-Difluoro-16-phenoxy-13,14-dihydro-PGF1, analogs
US4056556A (en) * 1975-02-24 1977-11-01 The Upjohn Company 2,2-Difluoro-16-phenoxy-PGE2 analogs
US4053502A (en) * 1975-10-02 1977-10-11 The Upjohn Company 4,4,5,5-Tetradehydro-ω-aryl-PGE1 analogs
US4013695A (en) * 1975-10-02 1977-03-22 The Upjohn Company 4,4,5,5-Tetradehydro-PGE1 analogs
US4053500A (en) * 1975-10-02 1977-10-11 The Upjohn Company 4,4,5,5-Tetradehydro-ω-aryl-PGF1α analogs
US5990168A (en) * 1996-04-18 1999-11-23 Alberta Cancer Board Methods and compositions for the treatment of ataxia telangiectasia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1040544A (en) * 1958-05-28 1966-09-01 Sune Bergstrom Improvements in or relating to therapeutic compounds and the manufacture thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1040544A (en) * 1958-05-28 1966-09-01 Sune Bergstrom Improvements in or relating to therapeutic compounds and the manufacture thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
REVUE AMERICAINE INLISTED DRUGS VOL. 18, NO 8. 1966, PAGE 69R, SE REFERANT A LA REVUE J. CLIN. INVEST. 45 : 1036, JUIN 1966 UP-JOHN ) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2183041A1 (en) * 1972-04-27 1973-12-14 Upjohn Co

Also Published As

Publication number Publication date
CH553740A (en) 1974-09-13
CH553739A (en) 1974-09-13
IL33949A0 (en) 1970-05-21
GB1282662A (en) 1972-07-19
IL33949A (en) 1976-06-30
FR2034951B1 (en) 1974-02-01
BR6915068D0 (en) 1973-05-24
BE747348A (en) 1970-09-14
GB1282661A (en) 1972-07-19
DE2011969A1 (en) 1970-10-08
CA968348A (en) 1975-05-27
ES377342A1 (en) 1973-01-01
NL7003298A (en) 1970-09-16
CH549549A (en) 1974-05-31

Similar Documents

Publication Publication Date Title
FR2059574B1 (en)
FR2034951B1 (en)
AU429630B2 (en)
AU5461069A (en)
AU2355770A (en)
CS150689B2 (en)
AU5712069A (en)
AU427401B2 (en)
CS148795B1 (en)
CS150642B2 (en)
AU442285B2 (en)
AU428129B2 (en)
AU428131B2 (en)
AU425297B2 (en)
AU438128B2 (en)
AU417208B2 (en)
AU414607B2 (en)
AU442322B2 (en)
AU410358B2 (en)
AU442357B2 (en)
AU428074B2 (en)
AT308690B (en)
AR203167Q (en)
AU5133369A (en)
CS150272B2 (en)

Legal Events

Date Code Title Description
ST Notification of lapse